| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.21e-06 | 262 | 123 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | AKT3 PLK2 FLT4 KALRN POLB UPRT AK9 CDK10 MYLK3 CHEK2 AKT1 AKT2 POLN ALK MUSK ALPK2 REV1 | 6.26e-05 | 938 | 123 | 17 | GO:0016772 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | EME1 RBBP8 POLB ZGRF1 ZC3H12B MSH3 DDX3X SLFN12L MLH3 CHD5 RCL1 POLN REV1 | 1.75e-04 | 645 | 123 | 13 | GO:0140640 |
| GeneOntologyMolecularFunction | kinase activity | AKT3 PLK2 FLT4 KALRN UPRT AK9 CDK10 MYLK3 CHEK2 AKT1 AKT2 ALK MUSK ALPK2 | 2.61e-04 | 764 | 123 | 14 | GO:0016301 |
| GeneOntologyMolecularFunction | protein kinase activity | AKT3 PLK2 FLT4 KALRN CDK10 MYLK3 CHEK2 AKT1 AKT2 ALK MUSK ALPK2 | 3.36e-04 | 600 | 123 | 12 | GO:0004672 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1A ZGRF1 AK9 MSH3 KATNAL1 PFN2 ABCA10 DDX3X KIF7 MLH3 CHD5 DNAH8 | 4.13e-04 | 614 | 123 | 12 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | AKT3 PLK2 FLT4 KALRN UPRT CDK10 MYLK3 CHEK2 AKT1 AKT2 ALK MUSK ALPK2 | 4.34e-04 | 709 | 123 | 13 | GO:0016773 |
| GeneOntologyMolecularFunction | DNA-directed DNA polymerase activity | 4.75e-04 | 25 | 123 | 3 | GO:0003887 | |
| GeneOntologyMolecularFunction | centromeric DNA binding | 7.75e-04 | 7 | 123 | 2 | GO:0019237 | |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 1.03e-03 | 8 | 123 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.14e-03 | 127 | 123 | 5 | GO:0008094 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 1.16e-03 | 190 | 123 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.39e-03 | 430 | 123 | 9 | GO:0004175 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.64e-03 | 38 | 123 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.65e-03 | 441 | 123 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 1.78e-03 | 446 | 123 | 9 | GO:0004674 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.80e-03 | 207 | 123 | 6 | GO:0008236 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.81e-03 | 84 | 123 | 4 | GO:0003684 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | 1.86e-03 | 363 | 123 | 8 | GO:0106310 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 2.02e-03 | 212 | 123 | 6 | GO:0017171 | |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | SEMA4D VLDLR LHFPL4 KALRN PPP1R9A HNRNPM SYBU KLK8 SEPTIN11 AKT1 MUSK | 2.15e-05 | 395 | 121 | 11 | GO:0050803 |
| GeneOntologyBiologicalProcess | synapse organization | SEMA4D VLDLR LHFPL4 KALRN PPFIBP1 PPP1R9A HNRNPM SORBS1 SYBU PFN2 KLK8 SEPTIN11 AKT1 MUSK | 4.96e-05 | 685 | 121 | 14 | GO:0050808 |
| GeneOntologyBiologicalProcess | DNA recombination | 6.33e-05 | 368 | 121 | 10 | GO:0006310 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | SEMA4D VLDLR LHFPL4 KALRN PPP1R9A HNRNPM KLK8 SEPTIN11 AKT1 MUSK | 9.59e-05 | 387 | 121 | 10 | GO:0050807 |
| GeneOntologyBiologicalProcess | DNA repair | EME1 RBBP8 RADX POLB ZGRF1 MSH3 MLH3 CHEK2 MRNIP ZFYVE26 SPATA22 POLN REV1 | 1.13e-04 | 648 | 121 | 13 | GO:0006281 |
| GeneOntologyBiologicalProcess | double-strand break repair | 1.26e-04 | 324 | 121 | 9 | GO:0006302 | |
| GeneOntologyBiologicalProcess | positive regulation of glycogen biosynthetic process | 1.51e-04 | 18 | 121 | 3 | GO:0045725 | |
| GeneOntologyBiologicalProcess | negative regulation of vasoconstriction | 1.51e-04 | 18 | 121 | 3 | GO:0045906 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | SEMA4D VLDLR FLT4 RGPD1 ATG14 PFN2 AR DDX3X CHEK2 MRNIP AKT1 AKT2 ALK MUSK | 1.95e-04 | 780 | 121 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | GPLD1 SEMA4D VLDLR FLT4 RGPD1 ATG14 PFN2 AR DDX3X CHEK2 MRNIP AKT1 AKT2 ALK MUSK | 1.97e-04 | 879 | 121 | 15 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | GPLD1 SEMA4D VLDLR FLT4 RGPD1 ATG14 PFN2 AR DDX3X CHEK2 MRNIP AKT1 AKT2 ALK MUSK | 1.97e-04 | 879 | 121 | 15 | GO:0010562 |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import across plasma membrane | 2.03e-04 | 4 | 121 | 2 | GO:0010748 | |
| GeneOntologyBiologicalProcess | cellular response to light intensity | 2.03e-04 | 4 | 121 | 2 | GO:0071484 | |
| GeneOntologyBiologicalProcess | negative regulation of long-chain fatty acid import into cell | 2.03e-04 | 4 | 121 | 2 | GO:0140213 | |
| Domain | Protein_kinase_ATP_BS | 2.06e-04 | 379 | 123 | 10 | IPR017441 | |
| Domain | PROTEIN_KINASE_ATP | 2.28e-04 | 459 | 123 | 11 | PS00107 | |
| Domain | Kinase-like_dom | AKT3 PLK2 FLT4 KALRN CDK10 MYLK3 CHEK2 AKT1 AKT2 ALK MUSK ALPK2 | 2.44e-04 | 542 | 123 | 12 | IPR011009 |
| Domain | Int_alpha | 2.50e-04 | 19 | 123 | 3 | SM00191 | |
| Domain | Int_alpha_beta-p | 2.50e-04 | 19 | 123 | 3 | IPR013519 | |
| Domain | TRYPSIN_SER | 3.21e-04 | 90 | 123 | 5 | IPR033116 | |
| Domain | Prot_kinase_dom | 3.91e-04 | 489 | 123 | 11 | IPR000719 | |
| Domain | FG_GAP | 3.92e-04 | 22 | 123 | 3 | PS51470 | |
| Domain | PROTEIN_KINASE_DOM | 4.18e-04 | 493 | 123 | 11 | PS50011 | |
| Domain | DOCK_N | 4.25e-04 | 5 | 123 | 2 | PF16172 | |
| Domain | DOCK_N | 4.25e-04 | 5 | 123 | 2 | IPR032376 | |
| Domain | FG-GAP | 5.10e-04 | 24 | 123 | 3 | PF01839 | |
| Domain | FG-GAP | 5.10e-04 | 24 | 123 | 3 | IPR013517 | |
| Domain | TRYPSIN_HIS | 5.97e-04 | 103 | 123 | 5 | IPR018114 | |
| Domain | TRYPSIN_SER | 6.81e-04 | 106 | 123 | 5 | PS00135 | |
| Domain | TRYPSIN_HIS | 7.10e-04 | 107 | 123 | 5 | PS00134 | |
| Domain | Pept_cys_AS | 8.10e-04 | 28 | 123 | 3 | IPR000169 | |
| Domain | RICIN | 8.10e-04 | 28 | 123 | 3 | SM00458 | |
| Domain | RICIN_B_LECTIN | 8.10e-04 | 28 | 123 | 3 | PS50231 | |
| Domain | Peptidase_S1A | 9.09e-04 | 113 | 123 | 5 | IPR001314 | |
| Domain | TRYPSIN_DOM | 9.84e-04 | 115 | 123 | 5 | PS50240 | |
| Domain | Ricin_B_lectin | 9.94e-04 | 30 | 123 | 3 | IPR000772 | |
| Domain | Tryp_SPc | 1.06e-03 | 117 | 123 | 5 | SM00020 | |
| Domain | Trypsin_dom | 1.23e-03 | 121 | 123 | 5 | IPR001254 | |
| Domain | Trypsin | 1.23e-03 | 121 | 123 | 5 | PF00089 | |
| Domain | Peptidase_S1_PA | 1.33e-03 | 123 | 123 | 5 | IPR009003 | |
| Domain | P-loop_NTPase | MYO1A ZGRF1 AK9 MSH3 KATNAL1 ABCA10 DDX3X KIF7 NLRP14 CHD5 SEPTIN11 MYO18B DNAH8 DYNC1LI2 | 1.39e-03 | 848 | 123 | 14 | IPR027417 |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 1.17e-07 | 8 | 92 | 4 | M47405 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 2.19e-06 | 15 | 92 | 4 | M47663 | |
| Pathway | KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY | 2.66e-06 | 5 | 92 | 3 | M48999 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.47e-06 | 102 | 92 | 7 | M39577 | |
| Pathway | WP_INTEGRINMEDIATED_CELL_ADHESION | 4.47e-06 | 102 | 92 | 7 | MM15830 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 5.30e-06 | 6 | 92 | 3 | M47523 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY | 9.24e-06 | 7 | 92 | 3 | M47407 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY | 9.24e-06 | 7 | 92 | 3 | M47790 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47395 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47404 | |
| Pathway | KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47803 | |
| Pathway | REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION | 1.47e-05 | 8 | 92 | 3 | M27806 | |
| Pathway | KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47482 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47498 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 1.47e-05 | 8 | 92 | 3 | M47715 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 1.63e-05 | 24 | 92 | 4 | M47460 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 1.93e-05 | 25 | 92 | 4 | M14301 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47397 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47392 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47391 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47402 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47802 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47481 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 2.20e-05 | 9 | 92 | 3 | MM15666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY | 2.20e-05 | 9 | 92 | 3 | M47972 | |
| Pathway | REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA | 2.28e-05 | 26 | 92 | 4 | MM15017 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY | 2.28e-05 | 26 | 92 | 4 | M47456 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.12e-05 | 10 | 92 | 3 | M47400 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY | 3.12e-05 | 10 | 92 | 3 | M47401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY | 3.12e-05 | 10 | 92 | 3 | M47615 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 3.12e-05 | 10 | 92 | 3 | M27095 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS | 3.12e-05 | 10 | 92 | 3 | MM14778 | |
| Pathway | REACTOME_FLT3_SIGNALING | 3.56e-05 | 29 | 92 | 4 | MM15652 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47797 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47403 | |
| Pathway | KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47499 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47756 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 4.27e-05 | 11 | 92 | 3 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.27e-05 | 11 | 92 | 3 | M47501 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 4.67e-05 | 31 | 92 | 4 | M47540 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY | 4.67e-05 | 31 | 92 | 4 | M47541 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 5.31e-05 | 32 | 92 | 4 | M14309 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY | 5.31e-05 | 32 | 92 | 4 | M47962 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.67e-05 | 12 | 92 | 3 | M47393 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350 | 5.67e-05 | 12 | 92 | 3 | M47798 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.67e-05 | 12 | 92 | 3 | M47558 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY | 5.67e-05 | 12 | 92 | 3 | M47559 | |
| Pathway | REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS | 5.67e-05 | 12 | 92 | 3 | M45022 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.67e-05 | 12 | 92 | 3 | MM15657 | |
| Pathway | REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS | 5.67e-05 | 12 | 92 | 3 | M27939 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 5.67e-05 | 12 | 92 | 3 | MM14777 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 5.67e-05 | 12 | 92 | 3 | MM14550 | |
| Pathway | REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING | 6.01e-05 | 33 | 92 | 4 | MM15027 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 7.34e-05 | 13 | 92 | 3 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 7.34e-05 | 13 | 92 | 3 | M47603 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | 7.34e-05 | 13 | 92 | 3 | M549 | |
| Pathway | REACTOME_REGULATION_OF_TP53_DEGRADATION | 8.53e-05 | 36 | 92 | 4 | MM15339 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 9.29e-05 | 14 | 92 | 3 | M47390 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 9.29e-05 | 14 | 92 | 3 | MM15341 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS | 9.29e-05 | 14 | 92 | 3 | M27638 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY | 9.29e-05 | 14 | 92 | 3 | M47467 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY | 9.29e-05 | 14 | 92 | 3 | M47536 | |
| Pathway | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | 9.29e-05 | 14 | 92 | 3 | M3862 | |
| Pathway | REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION | 9.51e-05 | 37 | 92 | 4 | M27641 | |
| Pathway | WP_NONSMALL_CELL_LUNG_CANCER | 1.05e-04 | 72 | 92 | 5 | M39738 | |
| Pathway | REACTOME_FLT3_SIGNALING | 1.06e-04 | 38 | 92 | 4 | M29803 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 1.16e-04 | 15 | 92 | 3 | M47389 | |
| Pathway | REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA | 1.16e-04 | 15 | 92 | 3 | M26902 | |
| Pathway | WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY | 1.16e-04 | 15 | 92 | 3 | M39431 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.16e-04 | 15 | 92 | 3 | M47475 | |
| Pathway | WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS | 1.16e-04 | 15 | 92 | 3 | M48306 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY | 1.16e-04 | 15 | 92 | 3 | M47971 | |
| Pathway | WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES | 1.71e-04 | 17 | 92 | 3 | M48086 | |
| Pathway | SA_PTEN_PATHWAY | 1.71e-04 | 17 | 92 | 3 | M12771 | |
| Pathway | SA_TRKA_RECEPTOR | 1.71e-04 | 17 | 92 | 3 | M18895 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 2.42e-04 | 19 | 92 | 3 | M39370 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY | 2.42e-04 | 19 | 92 | 3 | M47525 | |
| Pathway | WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER | 3.11e-04 | 50 | 92 | 4 | M39822 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.20e-04 | 199 | 92 | 7 | M7253 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | 3.29e-04 | 21 | 92 | 3 | M14966 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.29e-04 | 21 | 92 | 3 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.29e-04 | 21 | 92 | 3 | MM14996 | |
| Pathway | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | 3.36e-04 | 51 | 92 | 4 | M7955 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 3.79e-04 | 22 | 92 | 3 | M13897 | |
| Pathway | REACTOME_FOXO_MEDIATED_TRANSCRIPTION | 3.79e-04 | 22 | 92 | 3 | MM15656 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY | 3.79e-04 | 22 | 92 | 3 | M47919 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | SEMA4D VLDLR AKT3 KALRN ITGA9 PFN2 NCOR2 KLK8 AKT1 AKT2 KLK13 | 4.15e-04 | 502 | 92 | 11 | MM14537 |
| Pathway | KEGG_NON_SMALL_CELL_LUNG_CANCER | 4.19e-04 | 54 | 92 | 4 | M19818 | |
| Pathway | WP_SIGNAL_TRANSDUCTION_OF_S1P_RECEPTOR | 4.33e-04 | 23 | 92 | 3 | MM15952 | |
| Pathway | WP_SILDENAFIL_TREATMENT | 4.33e-04 | 23 | 92 | 3 | M46455 | |
| Pathway | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | 4.33e-04 | 23 | 92 | 3 | MM14993 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING | 4.93e-04 | 24 | 92 | 3 | M27952 | |
| Pathway | WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN | 5.58e-04 | 25 | 92 | 3 | M39533 | |
| Pathway | WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR | 5.58e-04 | 25 | 92 | 3 | M39794 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 5.58e-04 | 25 | 92 | 3 | M274 | |
| Pubmed | 2.34e-09 | 16 | 125 | 5 | 21624358 | ||
| Pubmed | DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport. | 1.08e-08 | 21 | 125 | 5 | 26529256 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 17912369 | ||
| Pubmed | Differential activation of AKT isoforms by growth factors in human myotubes. | 4.53e-08 | 3 | 125 | 3 | 37879895 | |
| Pubmed | Differential prognostic values of the three AKT isoforms in acute myeloid leukemia. | 4.53e-08 | 3 | 125 | 3 | 38528080 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 15987444 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 19825827 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 16540465 | ||
| Pubmed | Molecular alterations in AKT1, AKT2 and AKT3 detected in breast and prostatic cancer by FISH. | 4.53e-08 | 3 | 125 | 3 | 20102399 | |
| Pubmed | Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. | 4.53e-08 | 3 | 125 | 3 | 18561256 | |
| Pubmed | Differential effects of Akt isoforms on somatic cell reprogramming. | 4.53e-08 | 3 | 125 | 3 | 25037569 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 38396845 | ||
| Pubmed | AKT isoforms have distinct hippocampal expression and roles in synaptic plasticity. | 4.53e-08 | 3 | 125 | 3 | 29173281 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 21590431 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 29235817 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 34296180 | ||
| Pubmed | Sex differences in the mechanism of Met5-enkephalin-induced cardioprotection: role of PI3K/Akt. | 4.53e-08 | 3 | 125 | 3 | 17982014 | |
| Pubmed | Opposing functions of Akt isoforms in lung tumor initiation and progression. | 4.53e-08 | 3 | 125 | 3 | 24722238 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 24039187 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 16923958 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 17202487 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 26953242 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 23929892 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 19805051 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 25233414 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 21555366 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 32796067 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 25811375 | ||
| Pubmed | Akt/Protein kinase B is required for lymphatic network formation, remodeling, and valve development. | 4.53e-08 | 3 | 125 | 3 | 20724596 | |
| Pubmed | Akt Regulates Axon Wrapping and Myelin Sheath Thickness in the PNS. | 4.53e-08 | 3 | 125 | 3 | 27098694 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 28931550 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 10579998 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 20398329 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 33325370 | ||
| Pubmed | The Akt isoforms are present at distinct subcellular locations. | 4.53e-08 | 3 | 125 | 3 | 20018949 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 24247267 | ||
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 17895832 | ||
| Pubmed | Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. | 4.53e-08 | 3 | 125 | 3 | 10491192 | |
| Pubmed | 4.53e-08 | 3 | 125 | 3 | 17210696 | ||
| Pubmed | Role for Akt3/protein kinase Bgamma in attainment of normal brain size. | 4.53e-08 | 3 | 125 | 3 | 15713641 | |
| Pubmed | Protein kinase Akt2/PKBβ is involved in blastomere proliferation of preimplantation mouse embryos. | 1.81e-07 | 4 | 125 | 3 | 31552693 | |
| Pubmed | Differential effects of protein kinase B/Akt isoforms on glucose homeostasis and islet mass. | 1.81e-07 | 4 | 125 | 3 | 19933838 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 21242979 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 19435822 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 21507933 | ||
| Pubmed | Conditional inactivation of Akt three isoforms causes tau hyperphosphorylation in the brain. | 1.81e-07 | 4 | 125 | 3 | 26227811 | |
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 17942896 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 30567482 | ||
| Pubmed | 1.81e-07 | 4 | 125 | 3 | 21763505 | ||
| Pubmed | Cdc42 controls progenitor cell differentiation and beta-catenin turnover in skin. | 2.89e-07 | 39 | 125 | 5 | 16510873 | |
| Pubmed | The E3 ligase TTC3 facilitates ubiquitination and degradation of phosphorylated Akt. | 4.51e-07 | 5 | 125 | 3 | 20059950 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 9512493 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 27938661 | ||
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 26855332 | ||
| Pubmed | Unequal contribution of Akt isoforms in the double-negative to double-positive thymocyte transition. | 4.51e-07 | 5 | 125 | 3 | 17442925 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 22814751 | ||
| Pubmed | Leptin deficiency and beta-cell dysfunction underlie type 2 diabetes in compound Akt knockout mice. | 4.51e-07 | 5 | 125 | 3 | 19289493 | |
| Pubmed | Platelet-derived growth factor protects neurons against gp120-mediated toxicity. | 4.51e-07 | 5 | 125 | 3 | 18300076 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 25246356 | ||
| Pubmed | Brown fat organogenesis and maintenance requires AKT1 and AKT2. | 4.51e-07 | 5 | 125 | 3 | 30833219 | |
| Pubmed | 4.51e-07 | 5 | 125 | 3 | 36640312 | ||
| Pubmed | Spontaneous Hepatocellular Carcinoma after the Combined Deletion of Akt Isoforms. | 4.51e-07 | 5 | 125 | 3 | 26996309 | |
| Pubmed | Neutrophil AKT2 regulates heterotypic cell-cell interactions during vascular inflammation. | 8.99e-07 | 6 | 125 | 3 | 24642468 | |
| Pubmed | mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. | 8.99e-07 | 6 | 125 | 3 | 31996678 | |
| Pubmed | KCTD20, a relative of BTBD10, is a positive regulator of Akt. | 8.99e-07 | 6 | 125 | 3 | 24156551 | |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 14749824 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 23746211 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 12176997 | ||
| Pubmed | Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis. | 8.99e-07 | 6 | 125 | 3 | 29038421 | |
| Pubmed | Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. | 8.99e-07 | 6 | 125 | 3 | 10869418 | |
| Pubmed | Akt Regulates Sox10 Expression to Control Oligodendrocyte Differentiation via Phosphorylating FoxO1. | 8.99e-07 | 6 | 125 | 3 | 34385359 | |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 15616007 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 23673657 | ||
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 22107784 | ||
| Pubmed | Differential regulation of Akt kinase isoforms by the members of the TCL1 oncogene family. | 8.99e-07 | 6 | 125 | 3 | 11707444 | |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 21606541 | ||
| Pubmed | Protein kinase B alpha/Akt1 regulates placental development and fetal growth. | 8.99e-07 | 6 | 125 | 3 | 12783884 | |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 18160256 | ||
| Pubmed | AKT-dependent HspB1 (Hsp27) activity in epidermal differentiation. | 8.99e-07 | 6 | 125 | 3 | 17439945 | |
| Pubmed | 8.99e-07 | 6 | 125 | 3 | 20186503 | ||
| Pubmed | 9.08e-07 | 21 | 125 | 4 | 21576358 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 23968884 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 23786676 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 19261608 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 23604117 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 23811558 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 17634444 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 16287854 | ||
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 21697490 | ||
| Pubmed | The E3 ligase TRAF6 regulates Akt ubiquitination and activation. | 1.57e-06 | 7 | 125 | 3 | 19713527 | |
| Pubmed | 1.57e-06 | 7 | 125 | 3 | 21295499 | ||
| Pubmed | 2.05e-06 | 103 | 125 | 6 | 10574462 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 16841089 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 18826950 | ||
| Pubmed | Cell Adhesion Mediated by VCAM-ITGα9 Interactions Enables Lymphatic Development. | 2.50e-06 | 8 | 125 | 3 | 25745057 | |
| Pubmed | Deletion of Akt1 causes heart defects and abnormal cardiomyocyte proliferation. | 2.50e-06 | 8 | 125 | 3 | 20816796 | |
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 11208609 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 24590274 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 20040596 | ||
| Pubmed | 2.50e-06 | 8 | 125 | 3 | 24469921 | ||
| GeneFamily | DNA polymerases | 2.17e-04 | 23 | 93 | 3 | 535 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.13e-03 | 40 | 93 | 3 | 321 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.46e-03 | 161 | 93 | 5 | 593 | |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.52e-05 | 230 | 125 | 8 | M11563 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.60e-05 | 32 | 125 | 4 | M1558 | |
| Coexpression | BURTON_ADIPOGENESIS_12 | 1.60e-05 | 32 | 125 | 4 | MM668 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-08 | 196 | 124 | 8 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-08 | 196 | 124 | 8 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | severe-HSPC|severe / disease stage, cell group and cell class | 4.12e-07 | 165 | 124 | 7 | acd837d88ad3786c263f74651a6c0e02fa2fa2c5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.57e-07 | 187 | 124 | 7 | 35c382c0aabd46906113e5db30ea24bb8e658899 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 192 | 124 | 7 | b016e229300c183e14c0e2bba494bf49c7899112 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-06 | 192 | 124 | 7 | ac96831492c62ad9e1f7d0b764fbdf7d8a189ad9 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.21e-06 | 122 | 124 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.31e-06 | 196 | 124 | 7 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | severe_COVID-19-NK_CD56bright|World / disease group, cell group and cell class (v2) | 4.33e-06 | 152 | 124 | 6 | ab5a4e47b23d16018642d4c9c7f41b30205edf73 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.47e-06 | 163 | 124 | 6 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-06 | 164 | 124 | 6 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | mild_COVID-19_(asymptomatic)-cDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.09e-06 | 173 | 124 | 6 | 71dc0051c87b84e3cf13cde8858166f2a474b5dc | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 177 | 124 | 6 | 227d4f423b00be2e0c5797e2c5275d342e69a0f4 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 177 | 124 | 6 | 66ffa279147961080c104242a08b176e301d80e3 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-05 | 177 | 124 | 6 | 0cbf54608d2ba0a0500af142f2029fe5e118c3c2 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 180 | 124 | 6 | 493cf8d1a8f2a1ed2672f394a0338b110fd81d88 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 182 | 124 | 6 | f703963b5d1e8c1f95d78807521048553b0792d8 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.21e-05 | 182 | 124 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 1.21e-05 | 182 | 124 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-05 | 182 | 124 | 6 | ebd177ad5eac51bf2db0657596618bdf1e5d46e1 | |
| ToppCell | COVID-19-APC-like-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 1.25e-05 | 183 | 124 | 6 | 703364836b42aa6ac6c68b42b700ac23c4a1afc7 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 1.25e-05 | 183 | 124 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.29e-05 | 184 | 124 | 6 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | Endoth-Lymph|World / shred by cell class for parenchyma | 1.33e-05 | 185 | 124 | 6 | 97a6c4cd00684d4085d36ef32f7dbb99563ed357 | |
| ToppCell | Endothelial-endothelial_cell_of_lymph_vessel|World / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | 80910dcbb51990f2baed240f319456c0d3fa2065 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+VCAM1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-05 | 189 | 124 | 6 | c121817ddad164e9cfe382c43d0cbc9215508d02 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 189 | 124 | 6 | 0d18ea72bd58d32a8ab9a61cf97f5786642f804b | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-05 | 189 | 124 | 6 | bccb3481ffed597c845fe860da658505316105b5 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.50e-05 | 189 | 124 | 6 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.50e-05 | 189 | 124 | 6 | 55a1776a4ce049959b3f13a43744c7314bc1f00a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 190 | 124 | 6 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.59e-05 | 191 | 124 | 6 | 2f00d0b7b2ffce8eb3eb5bbae49a0d425b23c982 | |
| ToppCell | IPF-Endothelial-Lymphatic|IPF / Disease state, Lineage and Cell class | 1.64e-05 | 192 | 124 | 6 | 2496edd8f3a41146d418879de9ee2ccc7857431f | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 192 | 124 | 6 | 5e709c0714e8eba27e03a6def0544256bedb3ced | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_mature-Lymphatic_EC_mature_L.2.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.64e-05 | 192 | 124 | 6 | 35ffe7aa9ffab85eac3326651e901c39d0119650 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-05 | 192 | 124 | 6 | 5f4f44f15d3a2846981e68296643a4634930a211 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.69e-05 | 193 | 124 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-05 | 193 | 124 | 6 | 040f6bb42aa41d0921371fdda1cc0912c4fe1930 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.69e-05 | 193 | 124 | 6 | e468287c8b30c56d1de65e8347ade233ba6cf584 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-05 | 193 | 124 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_mature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.77e-05 | 115 | 124 | 5 | c3f6efb90d5ee01af831f65e240505faa6a71dc0 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 195 | 124 | 6 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 195 | 124 | 6 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | IPF-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.79e-05 | 195 | 124 | 6 | de88e9d22044b4b3e29676ad02b3e9299cc920ad | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 195 | 124 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | mild-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.79e-05 | 195 | 124 | 6 | 1e5f1967bcc898318f4e970b844b4a944eb168e5 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.85e-05 | 196 | 124 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | Endothelial_cells-Endothelial-B|Endothelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.85e-05 | 196 | 124 | 6 | 36f95f9ef74eb951e41ef46fd136ceaef45208fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 196 | 124 | 6 | c7136b1c83bcf907eec3b02b151fa061298b6672 | |
| ToppCell | Control-Endothelial-Lymphatic|Endothelial / Disease state, Lineage and Cell class | 1.85e-05 | 196 | 124 | 6 | e0cf617b0f5d9c3c19574f587a3d0ccbf93d8ca4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 196 | 124 | 6 | 145fcf73deba9638b391a1af6c39fa205dc9829f | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 196 | 124 | 6 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 1.85e-05 | 196 | 124 | 6 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | 1378c6d4ceb84b42fdd6556be3296df7a8059e6e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 199 | 124 | 6 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.01e-05 | 199 | 124 | 6 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.07e-05 | 200 | 124 | 6 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | severe-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.07e-05 | 200 | 124 | 6 | 2e67068b98696c313b815a2f0c98643f892e8bc0 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.07e-05 | 200 | 124 | 6 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 132 | 124 | 5 | 46c80eab16a70da9f363a9fbdf50bccab0b287d7 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 132 | 124 | 5 | a022c3c41654166cb106f27dc54fa88e8c40f898 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)--|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | 2121ba6a0beb2a8fdc589ff1063e7d8c2c3c68f6 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | cd6bca68fe52f451716fc8c0b1745984bc9ec057 | |
| ToppCell | Entopeduncular-Endothelial-ENDOTHELIAL_STALK-Flt1_1-Endothelial_Stalk.Flt1.Car4_(Car4)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 4.38e-05 | 70 | 124 | 4 | be300c0447735aba89df4c3082b81eb5abf22770 | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.92e-05 | 148 | 124 | 5 | f777aa1674e898e2594b2b7c029d3d05dda04df9 | |
| ToppCell | Adult-Immune-dendritic_cell-D122|Adult / Lineage, Cell type, age group and donor | 7.14e-05 | 154 | 124 | 5 | 64a4686586d08b1e9632dde917b472ac660de2d3 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 7.82e-05 | 157 | 124 | 5 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | d3446fc98eff09c3626b47a2c90d07cd985378b5 | |
| ToppCell | severe_COVID-19-NK_CD56bright|severe_COVID-19 / disease group, cell group and cell class (v2) | 8.06e-05 | 158 | 124 | 5 | c2e8d96fc29aa2388b92b4fd81d2726e1f7a053f | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.06e-05 | 158 | 124 | 5 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.06e-05 | 158 | 124 | 5 | df614450e10629dc9115d7365397663e82f9e48f | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.55e-05 | 160 | 124 | 5 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.55e-05 | 160 | 124 | 5 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.07e-05 | 162 | 124 | 5 | c399b9e4854916a59f5cae2d8dbf19660f8759be | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 162 | 124 | 5 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.07e-05 | 162 | 124 | 5 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.07e-05 | 162 | 124 | 5 | a291248b693c771845174393934a782f1d8bd7ce | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.33e-05 | 163 | 124 | 5 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 166 | 124 | 5 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-dnT|ICU-SEP / Disease, Lineage and Cell Type | 1.02e-04 | 166 | 124 | 5 | 96d92316cee20b722fe782db9dafcceb8f2c220b | |
| ToppCell | COVID-19-kidney-Lymphatic_EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.05e-04 | 167 | 124 | 5 | 97d0fea1f41c1c00e36d9b5c4c1f0dd85087056f | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 168 | 124 | 5 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.08e-04 | 168 | 124 | 5 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 169 | 124 | 5 | 606aa4ff25380d9470ec116ca86cd20f8b19587a | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 169 | 124 | 5 | 8caf7996796a2e2716e3855de855c903d6126bf2 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-04 | 169 | 124 | 5 | 052aae2af5446a0de071d5dda5381b0b9a0ed54d | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP3_(1)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.11e-04 | 169 | 124 | 5 | d9c3b22f62b882b8a2ea6fd9cf7afbe6d1775745 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 170 | 124 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 170 | 124 | 5 | 6035c92cd39c5ac54e7ec57d94888ee19f574639 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 170 | 124 | 5 | c8c42eda44b61440c96b202e7f54650046eb95d3 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_medulla-lymphatic_endothelial_cell_of_renal_medulla|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-04 | 170 | 124 | 5 | dcc64b73134e89ae37990d4878813b86ce91dae9 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-04 | 170 | 124 | 5 | 6210ee3bf29059e6149c047bb7e02c5f59441519 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 171 | 124 | 5 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / Disease condition and Cell class | 1.17e-04 | 171 | 124 | 5 | 5810f790012a0750ca3378595514f66a99f123be | |
| ToppCell | Endothelial-B-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-04 | 172 | 124 | 5 | 8a527dff06d841a86c7eb04a1dd9630787294da4 | |
| Drug | 2,4,6-TCA | 1.60e-06 | 5 | 125 | 3 | CID000012471 | |
| Disease | Malignant neoplasm of breast | KALRN GSDMB SORBS1 ITGA9 AR DDX3X C5orf34 NLRP14 SPATA21 CHD5 CHEK2 MKI67 AKT1 ZFYVE26 AKT2 ALK MACIR | 2.15e-06 | 1074 | 122 | 17 | C0006142 |
| Disease | Colorectal Neoplasms | 2.40e-06 | 277 | 122 | 9 | C0009404 | |
| Disease | endometrial cancer (is_implicated_in) | 1.48e-05 | 36 | 122 | 4 | DOID:1380 (is_implicated_in) | |
| Disease | Clumsiness - motor delay | 1.70e-05 | 2 | 122 | 2 | C0520947 | |
| Disease | Plasma Cell Granuloma, Pulmonary | 1.70e-05 | 2 | 122 | 2 | C0085269 | |
| Disease | Colorectal Carcinoma | KALRN ABCA10 POSTN MLH3 FBLN2 MYLK3 CHD5 GNB5 CHEK2 MKI67 AKT1 DNAH8 | 3.58e-05 | 702 | 122 | 12 | C0009402 |
| Disease | Neuroblastoma | 4.32e-05 | 47 | 122 | 4 | C0027819 | |
| Disease | Motor delay | 5.07e-05 | 3 | 122 | 2 | C1854301 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 6.37e-05 | 19 | 122 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 6.37e-05 | 19 | 122 | 3 | C2936783 | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 7.47e-05 | 20 | 122 | 3 | DOID:2526 (is_implicated_in) | |
| Disease | Adenocarcinoma of prostate | 7.47e-05 | 20 | 122 | 3 | C0007112 | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 7.54e-05 | 169 | 122 | 6 | DOID:3908 (is_marker_for) | |
| Disease | Endometrial cancer | 1.01e-04 | 4 | 122 | 2 | cv:C0007103 | |
| Disease | Breast Neoplasms, Male | 1.01e-04 | 4 | 122 | 2 | C0242788 | |
| Disease | ENDOMETRIAL CANCER | 1.01e-04 | 4 | 122 | 2 | 608089 | |
| Disease | Endometrial carcinoma | 1.01e-04 | 4 | 122 | 2 | cv:C0476089 | |
| Disease | Carcinoma of Male Breast | 1.01e-04 | 4 | 122 | 2 | C0238033 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.05e-04 | 112 | 122 | 5 | DOID:1793 (is_implicated_in) | |
| Disease | malignant astrocytoma (is_marker_for) | 1.15e-04 | 23 | 122 | 3 | DOID:3069 (is_marker_for) | |
| Disease | prostate cancer (is_implicated_in) | 1.29e-04 | 117 | 122 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | Neoplasm of the genitourinary tract | 1.31e-04 | 24 | 122 | 3 | cv:C0042065 | |
| Disease | colorectal cancer (is_implicated_in) | 1.51e-04 | 121 | 122 | 5 | DOID:9256 (is_implicated_in) | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 1.67e-04 | 26 | 122 | 3 | C0009405 | |
| Disease | Delayed speech and language development | 1.68e-04 | 5 | 122 | 2 | C0454644 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4) measurement | 1.68e-04 | 5 | 122 | 2 | EFO_0800417 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 1.88e-04 | 27 | 122 | 3 | C1112155 | |
| Disease | Adenocarcinoma of lung (disorder) | 2.22e-04 | 206 | 122 | 6 | C0152013 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 2.33e-04 | 29 | 122 | 3 | C1333990 | |
| Disease | ovarian neoplasm | 2.43e-04 | 134 | 122 | 5 | C0919267 | |
| Disease | persistent Staphylococcus aureus carrier status | 2.52e-04 | 6 | 122 | 2 | EFO_0007757 | |
| Disease | Malignant neoplasm of ovary | 2.69e-04 | 137 | 122 | 5 | C1140680 | |
| Disease | platelet measurement | 3.47e-04 | 315 | 122 | 7 | EFO_0005036 | |
| Disease | nasopharyngeal neoplasm | 4.21e-04 | 151 | 122 | 5 | EFO_0004252 | |
| Disease | eosinophil count | DOCK3 GPLD1 AKT3 MTF2 RBBP8 GSDMB ATG14 ITGA4 NCOR2 SLFN12L SLC9C1 KANSL1 RCL1 MED12L MUSK ALPK2 | 4.26e-04 | 1488 | 122 | 16 | EFO_0004842 |
| Disease | kallikrein-11 measurement | 5.99e-04 | 9 | 122 | 2 | EFO_0010573 | |
| Disease | Malignant tumor of prostate | 5.99e-04 | 9 | 122 | 2 | cv:C0376358 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 6.55e-04 | 41 | 122 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 6.55e-04 | 41 | 122 | 3 | C0858252 | |
| Disease | phosphatidylethanolamine ether measurement | 7.47e-04 | 10 | 122 | 2 | EFO_0010229 | |
| Disease | invasive ductal carcinoma (is_implicated_in) | 9.10e-04 | 11 | 122 | 2 | DOID:3008 (is_implicated_in) | |
| Disease | type 2 diabetes mellitus (implicated_via_orthology) | 9.64e-04 | 105 | 122 | 4 | DOID:9352 (implicated_via_orthology) | |
| Disease | neutrophil-to-lymphocyte ratio | 1.05e-03 | 185 | 122 | 5 | EFO_0008447 | |
| Disease | red blood cell density measurement | VLDLR KALRN SORBS1 PTPN3 KANSL1 RCL1 LY75 TVP23A SLC14A2 MUSK MACIR | 1.08e-03 | 880 | 122 | 11 | EFO_0007978 |
| Disease | Benign tumor of pancreas | 1.28e-03 | 13 | 122 | 2 | C0347284 | |
| Disease | urinary bladder cancer (biomarker_via_orthology) | 1.49e-03 | 14 | 122 | 2 | DOID:11054 (biomarker_via_orthology) | |
| Disease | delta-6 desaturase measurement | 1.72e-03 | 15 | 122 | 2 | EFO_0007765 | |
| Disease | cocaine dependence | 1.80e-03 | 58 | 122 | 3 | EFO_0002610 | |
| Disease | vitamin C measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0600003 | |
| Disease | phosphatidylcholine 32:2 measurement | 1.96e-03 | 16 | 122 | 2 | EFO_0010374 | |
| Disease | T-Cell Lymphoma | 1.96e-03 | 16 | 122 | 2 | C0079772 | |
| Disease | Polyposis, Adenomatous Intestinal | 1.96e-03 | 16 | 122 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 1.96e-03 | 16 | 122 | 2 | C2713443 | |
| Disease | Malignant Neoplasms | 2.00e-03 | 128 | 122 | 4 | C0006826 | |
| Disease | phosphoglyceric acid measurement | 2.21e-03 | 17 | 122 | 2 | EFO_0010523 | |
| Disease | Adenomatous Polyposis Coli | 2.21e-03 | 17 | 122 | 2 | C0032580 | |
| Disease | androgenetic alopecia | 2.30e-03 | 133 | 122 | 4 | EFO_0004191 | |
| Disease | myocardial infarction (implicated_via_orthology) | 2.61e-03 | 66 | 122 | 3 | DOID:5844 (implicated_via_orthology) | |
| Disease | Pancreatic carcinoma | 2.77e-03 | 19 | 122 | 2 | C0235974 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.07e-03 | 20 | 122 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | in situ carcinoma (is_marker_for) | 3.38e-03 | 21 | 122 | 2 | DOID:8719 (is_marker_for) | |
| Disease | nucleotide measurement | 3.47e-03 | 73 | 122 | 3 | EFO_0010513 | |
| Disease | breast cancer (is_implicated_in) | 3.54e-03 | 150 | 122 | 4 | DOID:1612 (is_implicated_in) | |
| Disease | eosinophil percentage of leukocytes | 3.89e-03 | 746 | 122 | 9 | EFO_0007991 | |
| Disease | Non-Small Cell Lung Carcinoma | 4.07e-03 | 156 | 122 | 4 | C0007131 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SIKMEKDSGCEGAAD | 536 | A9YTQ3 | |
| CKEGIKDGATMKTFC | 296 | P31749 | |
| LCKEGISDGATMKTF | 296 | P31751 | |
| KDGSQSKLGGETVDM | 676 | Q99708 | |
| GLGSKSGSMTKQELD | 1176 | Q8TDI0 | |
| NGAGKSTSIKMITGC | 1241 | Q8WWZ4 | |
| EIGMVANGTKCGDNK | 596 | Q9UKQ2 | |
| TICKGNEEMEKNSEG | 126 | Q6ZNE5 | |
| SVSKEGNTNCKGEGM | 621 | Q86TB3 | |
| EKSKMDCHGGISGTI | 26 | P22352 | |
| CLGKSLGSEDSRNMK | 241 | Q8TAX9 | |
| DMVCAGDAKGQKDSC | 196 | P49863 | |
| IMSKTLGSGACGEVK | 221 | O96017 | |
| CKGISSDGTANMTGK | 206 | Q8TCP9 | |
| GLCKEGITDAATMKT | 291 | Q9Y243 | |
| VVSMGTGTKCIGQSK | 61 | Q9BUB4 | |
| VDGLLACMKKGSISS | 546 | Q7Z5Q5 | |
| KDIQTGATGSGEMVC | 91 | Q9Y483 | |
| CGEELKGGDKVLMTC | 346 | Q9Y2P8 | |
| REKNCLGMKLSEDGT | 221 | Q8WWW0 | |
| GNTFVSGGCDKKAMV | 251 | O14775 | |
| EGSMAQLKKGLESGT | 631 | P26045 | |
| TEKMDVLGTVGSCGA | 106 | Q9ULE6 | |
| SGCLGTMEVKSKFGA | 11 | Q9BYG5 | |
| KITDNMLCAGTKEGG | 196 | Q9UKR3 | |
| MLCAGTKEGGKDSCE | 201 | Q9UKR3 | |
| EGTGVCFSKQPSSKM | 121 | Q6NTE8 | |
| GSCIFMCVKTSAKEG | 251 | A6NJZ3 | |
| TKSDSGEQKNMVIGG | 491 | Q6NSI4 | |
| SGVSVLSLCEKGDAM | 41 | Q9UQ80 | |
| EKRDLMACAQTGSGK | 216 | O00571 | |
| SDLGMSGNSEPKKCL | 111 | P20585 | |
| EGGMSVTQCSKEDGR | 1281 | Q9Y618 | |
| GCGLMEGKTTEAKTT | 756 | Q8IVU1 | |
| TCEPMGSLIDTKGNK | 1636 | Q86YW9 | |
| CPMELGQASGSASKK | 926 | Q86W92 | |
| GESGSGKTEASKLVM | 101 | Q9UBC5 | |
| MNGKEGVVECSFVKS | 266 | P40926 | |
| MENGKSKGCGVVKFE | 686 | P52272 | |
| GEDGSGKTTLMTKLQ | 61 | O43237 | |
| SKKDSEGIEMGVAGS | 296 | Q96MX6 | |
| EKSCMAGVLGAKEGE | 486 | P98095 | |
| KCTGGEESKAEAMPS | 76 | Q96GV9 | |
| ACLMSTKTEENGEAG | 1201 | Q9UHC1 | |
| GLGKTCLTTMDTKLN | 16 | Q32MK0 | |
| GKTETTKDMGRCLGK | 1851 | Q96JB1 | |
| GQKGSVAMAICDGSS | 586 | Q8NCW6 | |
| DLGGCNGTSSMAVIK | 2316 | O60229 | |
| KDSLGGNAKTVMIAC | 311 | Q2M1P5 | |
| SESGDLKGGMTNCTL | 196 | Q7Z3B3 | |
| NKSKSGVGRCSMLIA | 1626 | O60449 | |
| AKELCKAVSVSMGLG | 236 | P10275 | |
| QKGKGEAGNSDSMCL | 3186 | P46013 | |
| LCQTGKQAKISMGEE | 6 | Q8NGH3 | |
| DAETIRDMCGAKTGK | 151 | Q7Z7J7 | |
| GMSDLKCVQDAKGGS | 211 | Q86YT6 | |
| DGDCTMDIRTKSQGG | 81 | P35080 | |
| DMARGKNRGTSCGKT | 101 | Q13797 | |
| VKKTMVCAGGDGVIS | 196 | Q99895 | |
| CMKGEETENKKIGCT | 1206 | Q8IZD9 | |
| IGRMGAGEKKNACSV | 281 | Q8N1I0 | |
| MGEVDGKKIGCTVSL | 1171 | Q8N1I0 | |
| MTDKGCVKTADFGLA | 171 | Q15131 | |
| GCGMDSLNKKFSSAV | 256 | Q9UKA2 | |
| LTKGADGSKVMITHC | 586 | Q86SF2 | |
| GAVTKVKDQGMCGSC | 281 | Q9UBX1 | |
| SGADLGAVKTCEMCK | 701 | Q8NA82 | |
| LCNFGKMESGKEASV | 901 | P13612 | |
| QITDGMVCAGSSKGA | 191 | O60259 | |
| GSLDSTMKGKETLQG | 331 | Q96AY2 | |
| CKNIISLMDTSGNGK | 566 | O14815 | |
| KETLKKMSCVNGTEG | 206 | Q96MH7 | |
| KDCMNGGKCQEGKSE | 26 | Q0D2K5 | |
| GSGGHASNKEKEMIT | 3026 | P21817 | |
| SKMAKAGDIQSGGSD | 3476 | P21817 | |
| DTLSKGETKFMGVCQ | 226 | P06746 | |
| QKAMTAKGGDISVCE | 41 | P14854 | |
| SGAGEKLFSSQCGKM | 981 | P0DJD0 | |
| GAKNSVSLMKRGCEG | 306 | Q5JRS4 | |
| ENCNGKMATLSVGGK | 136 | P09001 | |
| GTGKTMLAKAVATEC | 251 | Q9BW62 | |
| GSGKTMCGRQLAEKL | 1001 | Q5TCS8 | |
| LMGIKSEDEAGCSSV | 371 | Q7L4I2 | |
| KKIMEACAGGFSSSV | 211 | Q8TEB9 | |
| CVGETGIGKSTLMDT | 46 | Q9NVA2 | |
| GAAESFGEKKGKCMS | 546 | Q4G0N8 | |
| SKISGCTMRGLDKNS | 181 | Q8NHS9 | |
| KEGTCKAQEMEAAVG | 341 | Q7Z572 | |
| FAEIKMENGKSKGCG | 551 | Q9P2K5 | |
| MENGKSKGCGTVRFD | 556 | Q9P2K5 | |
| CESMKTLGTLKGFQE | 1086 | Q5QGS0 | |
| GSGKLELSCMEGSCT | 551 | Q9NWF9 | |
| MSGDASVCPDKSKGS | 546 | Q92854 | |
| MSGGKVDEALVKSSC | 1246 | Q9UHV7 | |
| ALKNCSEGTSPGSKM | 421 | Q9UM73 | |
| KGDKMKIGCSTIEES | 456 | Q14246 | |
| EGQTGMAEKKLADCE | 36 | Q75MW2 | |
| SECGKGLTGKSMLIA | 571 | Q8N8J6 | |
| GSEKGKAGTATLAMS | 141 | Q7Z3J2 | |
| KQLICEEMGSVNKGS | 426 | Q6IEE8 | |
| MESKLASLGIKTCGD | 656 | Q9UBZ9 | |
| AGIMSGKRDACKGDS | 776 | Q7RTY8 | |
| GSDEGFTRKKCTIGM | 106 | Q9NX95 | |
| KTCKSMGECEVQKGG | 126 | Q8IYX0 | |
| SMGCLASEKGGKSSR | 776 | Q07617 | |
| MSSECDGGSKAVMNG | 1 | Q9BX66 | |
| GIHKGSSCDTVAVKM | 866 | P35916 | |
| YNGKETTLGDMTGKC | 761 | P80108 | |
| TEGSTGKTCLMKAVL | 111 | Q9Y5S1 | |
| AEDGEPQTCKSMKGS | 881 | Q709C8 | |
| MDAGKAGQTLKTHCS | 1 | Q8N661 | |
| VKTMSEGTLAKCGTG | 401 | Q5HYM0 | |
| EGTLAKCGTGMSSAK | 406 | Q5HYM0 | |
| TSSGLKMTGVDCVEG | 896 | Q8IUG5 | |
| GGDTTGKSQKTMCLQ | 111 | Q96MP5 | |
| FDMGICKTENTGKEI | 621 | Q86YA3 | |
| PAASTKMCEQALGKG | 11 | Q9NYY3 | |
| CKMGGNSDIGKVTAS | 171 | A6NH52 | |
| VCIENSCMEKGSKQG | 466 | Q15063 | |
| TGEMKECGEGLKDKS | 561 | Q15849 | |
| EGVKFEKGNCGVSIM | 171 | Q96BW1 | |
| GTCLTASMDGKIKLT | 726 | A4D1P6 | |
| LKCVSESGMAAKSDG | 2426 | Q68DK2 | |
| MASCDINGEDEKGGK | 51 | O14544 | |
| GLLKVSEGSKTCDTM | 91 | Q9ULM3 | |
| QMDLATGVCKAVGKE | 426 | P98155 | |
| CTCLKQQMEKGGDVT | 376 | Q86W24 | |
| GGAVESCGALQVKMK | 106 | O15146 | |
| KGDTMENLDGKQTSC | 846 | Q9ULJ8 | |
| MAGKDEGCKLVTIGS | 736 | Q14957 |